home / stock / bivi / bivi news


BIVI News and Press, BioVie Inc. From 10/24/22

Stock Information

Company Name: BioVie Inc.
Stock Symbol: BIVI
Market: NASDAQ
Website: biovieinc.com

Menu

BIVI BIVI Quote BIVI Short BIVI News BIVI Articles BIVI Message Board
Get BIVI Alerts

News, Short Squeeze, Breakout and More Instantly...

BIVI - BioVie to Present Data on Characterizing Hospitalization Burden of Ascites at AASLD Liver Meeting 2022

CARSON CITY, Nev., Oct. 24, 2022 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver di...

BIVI - BioVie's Phase 2 Trial Assessing NE3107's Pro-motoric Activity in Parkinson's Disease is Fully Enrolled

CARSON CITY, Nev., Oct. 19, 2022 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver di...

BIVI - An Overview Of Today's Alzheimer's Disease Development Field

Summary Alzheimer's Disease is one of the largest unmet medical needs. Today, there are 139 drugs in clinical trials for Alzheimer's. In this piece, we dive into 8 of the most impactful and promising trials. Introduction Alzheimer's disease is the largest unmet...

BIVI - BioVie: Recent Data In Alzheimer's Suggests +100% Upside Potential Within A Year

Summary BioVie recently presented one of the best cognition improvements ever reported in an open label study in Alzheimer’s disease. Further reporting and biomarkers confirmed those improvements, making BioVie a serious contender in the Alzheimer’s space. A Phas...

BIVI - BioVie Issues Letter to Shareholders

Positive preliminary data from investigator-sponsored Phase 2 Alzheimer’s trial show high proportion of responders and level of cognitive improvements seen for NE3107 confirm NE3107’s status as one of the most promising candidates in the Alzheimer’s space ...

BIVI - BioVie to Participate in Cantor Fitzgerald's Neurology & Psychiatry Conference

RENO, Nev., Sept. 29, 2022 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, tod...

BIVI - BioVie Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

ORLANDO, FL / ACCESSWIRE / September 15, 2022 / RedChip Companies will air a new interview with BioVie Inc. (NASDAQ:BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative ...

BIVI - What Is Going on With Getty Images (GETY) Stock Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/360b Getty Images (NYSE: GETY ) stock is sliding on Wednesday even after renewing a multi-year contract with Amazon (NYSE: AMZN ). According to the company, this agreement wi...

BIVI - Is Tandy Leather Factory (TLFA) Stock the Next Big Squeeze?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Alextype/Shutterstock.com Tandy Leather Factory (OTCMKTS: TLFA ) stock is on the move Wednesday as investors react to the company uplisting its shares to the Nasdaq Exchange. That uplisting is set to...

BIVI - What Is Going on With Sidus Space (SIDU) Stock Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: NicoElNino / Shutterstock.com Sidus Space (NASDAQ: SIDU ) stock is rising higher on Wednesday after the company announced an agreement with Elon Musk’s SpaceX . That agreement has Sidus Space...

Previous 10 Next 10